Adalimumab combined with ciprofloxacin is superior to adalimumab monotherapy in perianal fistula closure in Crohn's disease: a randomised, double-blind, placebo controlled trial (ADAFI)

Long-term MRI-guided combined anti-TNF-α and thiopurine therapy for crohnʼs perianal fistulas

(2012) Phil Tozer et al.   INFLAMMATORY BOWEL DISEASES

OP20 TNF and MDP induce epithelial-to-mesenchymal transition in human intestinal cells: Implications for the pathogenesis of Crohn's disease-associated fistulae and the use of anti-TNF antibodies

(2012) M. Scharl et al.   Journal of Crohns & Colitis

Autologous bone marrow-derived mesenchymal stromal cells in the treatment of fistulising Crohn's disease

(2011) R. Ciccocioppo et al.   GUT

The CHOICE trial: adalimumab demonstrates safety, fistula healing, improved quality of life and increased work productivity in patients with Crohn’s disease who failed prior infliximab therapy

(2010) S. Lichtiger et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Long-Term Monitoring of Infliximab Therapy for Perianal Fistulizing Crohn's Disease by Using Magnetic Resonance Imaging

(2010) Konstantinos Karmiris et al.   Clinical Gastroenterology and Hepatology

Prospective Evaluation of Anti-Tumor Necrosis Factor Therapy Guided by Magnetic Resonance Imaging for Crohn's Perineal Fistulas

(2009) Siew C Ng et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

An open study of maintenance antibiotic therapy for chronic antibiotic-dependent pouchitis: efficacy, complications and outcome

(2009) S. D. McLaughlin et al.   Colorectal Disease

Adalimumab for the treatment of fistulas in patients with Crohn's disease

(2009) J-F Colombel et al.   GUT

Impact of demographic factors, medication and symptoms on disease-specific quality of life in inflammatory bowel disease

(2009) Johanna Haapamäki et al.   QUALITY OF LIFE RESEARCH

Ciprofloxacin or metronidazole for the treatment of perianal fistulas in patients with Crohnʼs disease: A randomized, double-blind, placebo-controlled pilot study

(2008) Kelvin T. Thia et al.   INFLAMMATORY BOWEL DISEASES

Early stopping of randomized clinical trials for overt efficacy is problematic

(2008) Dirk Bassler et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY